GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ESRRA
|
ENSG00000173153.9 | estrogen related receptor alpha |
ESR2
|
ENSG00000140009.14 | estrogen receptor 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ESR2 | hg19_v2_chr14_-_64761078_64761128 | 0.37 | 1.9e-08 | Click! |
ESRRA | hg19_v2_chr11_+_64073699_64073918 | 0.31 | 2.1e-06 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_106174960 | 137.89 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
chr22_+_23237555 | 101.06 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 (Mcg marker) |
chr22_+_23248512 | 100.61 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
chr22_+_23243156 | 91.62 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
chr14_-_106209368 | 90.70 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
chr14_-_106054659 | 86.73 |
ENST00000390539.2
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
chr22_+_23264766 | 74.03 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr22_+_23241661 | 61.89 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr22_+_23247030 | 61.15 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr22_+_23229960 | 58.05 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
chr6_+_33043703 | 57.05 |
ENST00000418931.2
ENST00000535465.1 |
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr16_+_222846 | 54.47 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
chr14_-_106237742 | 49.22 |
ENST00000390551.2
|
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
chr14_-_106330072 | 46.52 |
ENST00000488476.1
|
IGHJ5
|
immunoglobulin heavy joining 5 |
chr14_-_106322288 | 40.32 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
chr6_-_167369612 | 38.92 |
ENST00000507747.1
|
RP11-514O12.4
|
RP11-514O12.4 |
chr11_+_67033881 | 38.90 |
ENST00000308595.5
ENST00000526285.1 |
ADRBK1
|
adrenergic, beta, receptor kinase 1 |
chr6_-_32498046 | 38.72 |
ENST00000374975.3
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5 |
chr2_+_85804614 | 37.47 |
ENST00000263864.5
ENST00000409760.1 |
VAMP8
|
vesicle-associated membrane protein 8 |
chr14_-_106642049 | 32.32 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
chr19_+_1065922 | 32.03 |
ENST00000539243.2
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr19_-_36399149 | 29.77 |
ENST00000585901.2
ENST00000544690.2 ENST00000424586.3 ENST00000262629.4 ENST00000589517.1 |
TYROBP
|
TYRO protein tyrosine kinase binding protein |
chr14_-_24911868 | 27.49 |
ENST00000554698.1
|
SDR39U1
|
short chain dehydrogenase/reductase family 39U, member 1 |
chr22_-_17680472 | 27.16 |
ENST00000330232.4
|
CECR1
|
cat eye syndrome chromosome region, candidate 1 |
chr7_-_150498426 | 26.96 |
ENST00000447204.2
|
TMEM176B
|
transmembrane protein 176B |
chr22_+_23040274 | 26.92 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr14_-_94856987 | 26.90 |
ENST00000449399.3
ENST00000404814.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr2_-_89310012 | 26.86 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr14_-_94857004 | 26.84 |
ENST00000557492.1
ENST00000448921.1 ENST00000437397.1 ENST00000355814.4 ENST00000393088.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr19_-_39826639 | 26.30 |
ENST00000602185.1
ENST00000598034.1 ENST00000601387.1 ENST00000595636.1 ENST00000253054.8 ENST00000594700.1 ENST00000597595.1 |
GMFG
|
glia maturation factor, gamma |
chr4_+_668348 | 26.08 |
ENST00000511290.1
|
MYL5
|
myosin, light chain 5, regulatory |
chr19_+_42381173 | 25.95 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr19_+_1041212 | 25.45 |
ENST00000433129.1
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7 |
chr21_-_46330545 | 25.18 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr11_-_73687997 | 24.92 |
ENST00000545212.1
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr14_-_94856951 | 24.91 |
ENST00000553327.1
ENST00000556955.1 ENST00000557118.1 ENST00000440909.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr1_-_111743285 | 24.59 |
ENST00000357640.4
|
DENND2D
|
DENN/MADD domain containing 2D |
chr13_+_42031679 | 24.28 |
ENST00000379359.3
|
RGCC
|
regulator of cell cycle |
chr6_+_29691198 | 24.14 |
ENST00000440587.2
ENST00000434407.2 |
HLA-F
|
major histocompatibility complex, class I, F |
chr17_+_78075361 | 23.95 |
ENST00000577106.1
ENST00000390015.3 |
GAA
|
glucosidase, alpha; acid |
chr19_+_18284477 | 23.73 |
ENST00000407280.3
|
IFI30
|
interferon, gamma-inducible protein 30 |
chr2_-_89157161 | 23.63 |
ENST00000390237.2
|
IGKC
|
immunoglobulin kappa constant |
chr2_-_89513402 | 23.30 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr12_+_112204691 | 23.17 |
ENST00000416293.3
ENST00000261733.2 |
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial) |
chr22_+_23134974 | 22.91 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr19_+_859425 | 22.58 |
ENST00000327726.6
|
CFD
|
complement factor D (adipsin) |
chr3_+_45071622 | 21.84 |
ENST00000428034.1
|
CLEC3B
|
C-type lectin domain family 3, member B |
chr16_-_88717423 | 21.66 |
ENST00000568278.1
ENST00000569359.1 ENST00000567174.1 |
CYBA
|
cytochrome b-245, alpha polypeptide |
chr19_+_1067492 | 21.56 |
ENST00000586866.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr14_-_24911971 | 21.56 |
ENST00000555365.1
ENST00000399395.3 |
SDR39U1
|
short chain dehydrogenase/reductase family 39U, member 1 |
chr3_+_45067659 | 21.42 |
ENST00000296130.4
|
CLEC3B
|
C-type lectin domain family 3, member B |
chr6_+_31916733 | 20.95 |
ENST00000483004.1
|
CFB
|
complement factor B |
chr14_-_106111127 | 20.71 |
ENST00000390545.2
|
IGHG2
|
immunoglobulin heavy constant gamma 2 (G2m marker) |
chr6_+_31554962 | 20.14 |
ENST00000376092.3
ENST00000376086.3 ENST00000303757.8 ENST00000376093.2 ENST00000376102.3 |
LST1
|
leukocyte specific transcript 1 |
chr2_-_89266286 | 20.04 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
chr5_-_149792295 | 19.64 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr1_+_22962948 | 19.54 |
ENST00000374642.3
|
C1QA
|
complement component 1, q subcomponent, A chain |
chr6_+_31555045 | 19.50 |
ENST00000396101.3
ENST00000490742.1 |
LST1
|
leukocyte specific transcript 1 |
chr6_+_33172407 | 19.50 |
ENST00000374662.3
|
HSD17B8
|
hydroxysteroid (17-beta) dehydrogenase 8 |
chrX_+_46940254 | 19.35 |
ENST00000336169.3
|
RGN
|
regucalcin |
chr11_+_313503 | 19.33 |
ENST00000528780.1
ENST00000328221.5 |
IFITM1
|
interferon induced transmembrane protein 1 |
chr11_-_73689037 | 19.15 |
ENST00000544615.1
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr2_-_89278535 | 18.37 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chr1_+_119957554 | 18.30 |
ENST00000543831.1
ENST00000433745.1 ENST00000369416.3 |
HSD3B2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
chr2_-_89442621 | 18.28 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr1_-_229569834 | 18.19 |
ENST00000366684.3
ENST00000366683.2 |
ACTA1
|
actin, alpha 1, skeletal muscle |
chr14_-_24911448 | 18.18 |
ENST00000555355.1
ENST00000553343.1 ENST00000556523.1 ENST00000556249.1 ENST00000538105.2 ENST00000555225.1 |
SDR39U1
|
short chain dehydrogenase/reductase family 39U, member 1 |
chr1_-_173886491 | 18.12 |
ENST00000367698.3
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1 |
chr16_+_226658 | 17.91 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
chr9_-_116840728 | 17.85 |
ENST00000265132.3
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
chr7_+_150498783 | 17.80 |
ENST00000475536.1
ENST00000468689.1 |
TMEM176A
|
transmembrane protein 176A |
chr11_-_118213331 | 17.73 |
ENST00000392884.2
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
chr11_-_116968987 | 17.69 |
ENST00000434315.2
ENST00000292055.4 ENST00000375288.1 ENST00000542607.1 ENST00000445177.1 ENST00000375300.1 ENST00000446921.2 |
SIK3
|
SIK family kinase 3 |
chr2_-_136875712 | 17.63 |
ENST00000241393.3
|
CXCR4
|
chemokine (C-X-C motif) receptor 4 |
chr16_-_88717482 | 17.57 |
ENST00000261623.3
|
CYBA
|
cytochrome b-245, alpha polypeptide |
chr16_+_30194916 | 17.45 |
ENST00000570045.1
ENST00000565497.1 ENST00000570244.1 |
CORO1A
|
coronin, actin binding protein, 1A |
chr1_-_31230650 | 17.32 |
ENST00000294507.3
|
LAPTM5
|
lysosomal protein transmembrane 5 |
chr3_-_50340996 | 17.30 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
chr11_-_64512273 | 17.25 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr2_-_89292422 | 17.05 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr16_+_85942594 | 17.01 |
ENST00000566369.1
|
IRF8
|
interferon regulatory factor 8 |
chr6_-_32557610 | 17.00 |
ENST00000360004.5
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1 |
chr14_+_92980111 | 16.93 |
ENST00000216487.7
ENST00000557762.1 |
RIN3
|
Ras and Rab interactor 3 |
chr17_-_76123101 | 16.91 |
ENST00000392467.3
|
TMC6
|
transmembrane channel-like 6 |
chr6_+_32709119 | 16.87 |
ENST00000374940.3
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
chr11_+_57365150 | 16.81 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
chr3_+_14989186 | 16.80 |
ENST00000435454.1
ENST00000323373.6 |
NR2C2
|
nuclear receptor subfamily 2, group C, member 2 |
chr8_+_142402089 | 16.75 |
ENST00000521578.1
ENST00000520105.1 ENST00000523147.1 |
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3 |
chr19_+_859654 | 16.47 |
ENST00000592860.1
|
CFD
|
complement factor D (adipsin) |
chr12_-_117537240 | 16.47 |
ENST00000392545.4
ENST00000541210.1 ENST00000335209.7 |
TESC
|
tescalcin |
chr14_+_24630465 | 16.45 |
ENST00000557894.1
ENST00000559284.1 ENST00000560275.1 |
IRF9
|
interferon regulatory factor 9 |
chrX_-_106960285 | 16.45 |
ENST00000503515.1
ENST00000372397.2 |
TSC22D3
|
TSC22 domain family, member 3 |
chr19_-_10450287 | 16.42 |
ENST00000589261.1
ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3
|
intercellular adhesion molecule 3 |
chr1_-_151345159 | 16.32 |
ENST00000458566.1
ENST00000447402.3 ENST00000426705.2 ENST00000435071.1 ENST00000368868.5 |
SELENBP1
|
selenium binding protein 1 |
chr19_+_35773242 | 16.21 |
ENST00000222304.3
|
HAMP
|
hepcidin antimicrobial peptide |
chr22_-_51021397 | 16.10 |
ENST00000406938.2
|
CHKB
|
choline kinase beta |
chr1_+_152635854 | 16.09 |
ENST00000368784.1
|
LCE2D
|
late cornified envelope 2D |
chr2_+_219264466 | 16.07 |
ENST00000273062.2
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
chr11_-_5271122 | 15.94 |
ENST00000330597.3
|
HBG1
|
hemoglobin, gamma A |
chr4_-_2264015 | 15.92 |
ENST00000337190.2
|
MXD4
|
MAX dimerization protein 4 |
chr1_+_28199047 | 15.81 |
ENST00000373925.1
ENST00000328928.7 ENST00000373927.3 ENST00000427466.1 ENST00000442118.1 ENST00000373921.3 |
THEMIS2
|
thymocyte selection associated family member 2 |
chr7_-_150038704 | 15.81 |
ENST00000466675.1
ENST00000482669.1 ENST00000467793.1 ENST00000223271.3 |
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2 |
chr19_+_10197463 | 15.78 |
ENST00000590378.1
ENST00000397881.3 |
C19orf66
|
chromosome 19 open reading frame 66 |
chr17_+_4854375 | 15.74 |
ENST00000521811.1
ENST00000519602.1 ENST00000323997.6 ENST00000522249.1 ENST00000519584.1 |
ENO3
|
enolase 3 (beta, muscle) |
chr14_-_106406090 | 15.72 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
chr19_-_13213662 | 15.54 |
ENST00000264824.4
|
LYL1
|
lymphoblastic leukemia derived sequence 1 |
chr7_-_95025661 | 15.50 |
ENST00000542556.1
ENST00000265627.5 ENST00000427422.1 ENST00000451904.1 |
PON1
PON3
|
paraoxonase 1 paraoxonase 3 |
chr19_-_39108568 | 15.50 |
ENST00000586296.1
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
chr22_-_17702729 | 15.40 |
ENST00000449907.2
ENST00000441548.1 ENST00000399839.1 |
CECR1
|
cat eye syndrome chromosome region, candidate 1 |
chr11_-_64511575 | 15.39 |
ENST00000431822.1
ENST00000377486.3 ENST00000394432.3 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr17_+_78075498 | 15.36 |
ENST00000302262.3
|
GAA
|
glucosidase, alpha; acid |
chr11_-_407103 | 15.35 |
ENST00000526395.1
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr4_-_71532339 | 15.27 |
ENST00000254801.4
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr17_-_34207295 | 15.26 |
ENST00000463941.1
ENST00000293272.3 |
CCL5
|
chemokine (C-C motif) ligand 5 |
chr19_-_19754404 | 15.15 |
ENST00000587205.1
ENST00000445806.2 ENST00000203556.4 |
GMIP
|
GEM interacting protein |
chr22_-_36013368 | 15.15 |
ENST00000442617.1
ENST00000397326.2 ENST00000397328.1 ENST00000451685.1 |
MB
|
myoglobin |
chr6_-_32636145 | 15.12 |
ENST00000399084.1
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1 |
chr14_+_23016437 | 15.05 |
ENST00000478163.3
|
TRAC
|
T cell receptor alpha constant |
chr9_-_137809718 | 15.05 |
ENST00000371806.3
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1 |
chr12_+_121163538 | 15.03 |
ENST00000242592.4
|
ACADS
|
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
chr2_-_89619904 | 14.92 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
chr16_+_30710462 | 14.83 |
ENST00000262518.4
ENST00000395059.2 ENST00000344771.4 |
SRCAP
|
Snf2-related CREBBP activator protein |
chr14_-_106330458 | 14.81 |
ENST00000461719.1
|
IGHJ4
|
immunoglobulin heavy joining 4 |
chr15_-_45670924 | 14.62 |
ENST00000396659.3
|
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
chr3_-_52486841 | 14.61 |
ENST00000496590.1
|
TNNC1
|
troponin C type 1 (slow) |
chr19_+_45409011 | 14.59 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
chr6_+_31554779 | 14.56 |
ENST00000376090.2
|
LST1
|
leukocyte specific transcript 1 |
chr19_-_6690723 | 14.52 |
ENST00000601008.1
|
C3
|
complement component 3 |
chr1_+_209929494 | 14.50 |
ENST00000367026.3
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr22_+_22936998 | 14.40 |
ENST00000390303.2
|
IGLV3-32
|
immunoglobulin lambda variable 3-32 (non-functional) |
chr22_+_22712087 | 14.40 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr22_+_23089870 | 14.28 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
chr12_-_122296755 | 14.28 |
ENST00000289004.4
|
HPD
|
4-hydroxyphenylpyruvate dioxygenase |
chr19_+_1205740 | 14.25 |
ENST00000326873.7
|
STK11
|
serine/threonine kinase 11 |
chr12_-_15104040 | 14.21 |
ENST00000541644.1
ENST00000545895.1 |
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chrX_+_44732757 | 14.08 |
ENST00000377967.4
ENST00000536777.1 ENST00000382899.4 ENST00000543216.1 |
KDM6A
|
lysine (K)-specific demethylase 6A |
chr17_-_2614927 | 14.06 |
ENST00000435359.1
|
CLUH
|
clustered mitochondria (cluA/CLU1) homolog |
chr16_-_28937027 | 14.02 |
ENST00000358201.4
|
RABEP2
|
rabaptin, RAB GTPase binding effector protein 2 |
chr9_+_140513438 | 13.98 |
ENST00000462484.1
ENST00000334856.6 ENST00000460843.1 |
EHMT1
|
euchromatic histone-lysine N-methyltransferase 1 |
chr2_+_90139056 | 13.90 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr22_+_47158518 | 13.84 |
ENST00000337137.4
ENST00000380995.1 ENST00000407381.3 |
TBC1D22A
|
TBC1 domain family, member 22A |
chr19_-_10446449 | 13.84 |
ENST00000592439.1
|
ICAM3
|
intercellular adhesion molecule 3 |
chr14_+_105952648 | 13.72 |
ENST00000330233.7
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
chr7_+_142960505 | 13.71 |
ENST00000409500.3
ENST00000443571.2 ENST00000358406.5 ENST00000479303.1 |
GSTK1
|
glutathione S-transferase kappa 1 |
chr14_-_21492113 | 13.65 |
ENST00000554094.1
|
NDRG2
|
NDRG family member 2 |
chrX_-_70331298 | 13.64 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
chr2_+_90248739 | 13.60 |
ENST00000468879.1
|
IGKV1D-43
|
immunoglobulin kappa variable 1D-43 |
chr7_+_150264365 | 13.52 |
ENST00000255945.2
ENST00000461940.1 |
GIMAP4
|
GTPase, IMAP family member 4 |
chr19_+_42301079 | 13.49 |
ENST00000596544.1
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3 |
chr22_+_23101182 | 13.47 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr14_+_105953246 | 13.43 |
ENST00000392531.3
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
chr8_-_6837602 | 13.41 |
ENST00000382692.2
|
DEFA1
|
defensin, alpha 1 |
chr15_-_78423763 | 13.39 |
ENST00000557846.1
|
CIB2
|
calcium and integrin binding family member 2 |
chr14_-_107095662 | 13.38 |
ENST00000390630.2
|
IGHV4-61
|
immunoglobulin heavy variable 4-61 |
chr22_+_37257015 | 13.37 |
ENST00000447071.1
ENST00000248899.6 ENST00000397147.4 |
NCF4
|
neutrophil cytosolic factor 4, 40kDa |
chr6_+_89790459 | 13.34 |
ENST00000369472.1
|
PNRC1
|
proline-rich nuclear receptor coactivator 1 |
chr14_-_101295407 | 13.27 |
ENST00000596284.1
|
AL117190.2
|
AL117190.2 |
chr2_+_90077680 | 13.23 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr19_-_51568324 | 13.18 |
ENST00000595547.1
ENST00000335422.3 ENST00000595793.1 ENST00000596955.1 |
KLK13
|
kallikrein-related peptidase 13 |
chr15_-_22473353 | 13.17 |
ENST00000557788.2
|
IGHV4OR15-8
|
immunoglobulin heavy variable 4/OR15-8 (non-functional) |
chr1_-_104239076 | 13.11 |
ENST00000370080.3
|
AMY1B
|
amylase, alpha 1B (salivary) |
chr6_+_6588316 | 13.11 |
ENST00000379953.2
|
LY86
|
lymphocyte antigen 86 |
chr4_-_926069 | 13.10 |
ENST00000314167.4
ENST00000502656.1 |
GAK
|
cyclin G associated kinase |
chr6_+_89790490 | 13.07 |
ENST00000336032.3
|
PNRC1
|
proline-rich nuclear receptor coactivator 1 |
chr6_-_31324943 | 13.07 |
ENST00000412585.2
ENST00000434333.1 |
HLA-B
|
major histocompatibility complex, class I, B |
chr19_+_2389784 | 12.97 |
ENST00000332578.3
|
TMPRSS9
|
transmembrane protease, serine 9 |
chr14_-_106733624 | 12.97 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
chr2_-_89385283 | 12.89 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chr6_+_33048222 | 12.88 |
ENST00000428835.1
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr6_+_32605134 | 12.86 |
ENST00000343139.5
ENST00000395363.1 ENST00000496318.1 |
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
chr18_+_29171689 | 12.85 |
ENST00000237014.3
|
TTR
|
transthyretin |
chr2_+_90153696 | 12.85 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
chr19_-_54872556 | 12.85 |
ENST00000444687.1
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1 |
chr7_+_150498610 | 12.81 |
ENST00000461345.1
|
TMEM176A
|
transmembrane protein 176A |
chr1_-_24194771 | 12.80 |
ENST00000374479.3
|
FUCA1
|
fucosidase, alpha-L- 1, tissue |
chr14_-_107283278 | 12.74 |
ENST00000390639.2
|
IGHV7-81
|
immunoglobulin heavy variable 7-81 (non-functional) |
chr19_-_55668093 | 12.70 |
ENST00000588882.1
ENST00000586858.1 |
TNNI3
|
troponin I type 3 (cardiac) |
chr2_+_220492116 | 12.65 |
ENST00000373760.2
|
SLC4A3
|
solute carrier family 4 (anion exchanger), member 3 |
chr9_+_74526384 | 12.59 |
ENST00000334731.2
ENST00000377031.3 |
C9orf85
|
chromosome 9 open reading frame 85 |
chr19_+_5623186 | 12.57 |
ENST00000538656.1
|
SAFB
|
scaffold attachment factor B |
chr1_+_38022513 | 12.52 |
ENST00000296218.7
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
chr14_-_24780573 | 12.51 |
ENST00000336557.5
ENST00000258807.5 |
CIDEB
|
cell death-inducing DFFA-like effector b |
chr1_+_22963158 | 12.50 |
ENST00000438241.1
|
C1QA
|
complement component 1, q subcomponent, A chain |
chr17_-_62097904 | 12.49 |
ENST00000583366.1
|
ICAM2
|
intercellular adhesion molecule 2 |
chr22_-_39636914 | 12.48 |
ENST00000381551.4
|
PDGFB
|
platelet-derived growth factor beta polypeptide |
chr5_-_149492904 | 12.45 |
ENST00000286301.3
ENST00000511344.1 |
CSF1R
|
colony stimulating factor 1 receptor |
chr11_+_65405556 | 12.42 |
ENST00000534313.1
ENST00000533361.1 ENST00000526137.1 |
SIPA1
|
signal-induced proliferation-associated 1 |
chr19_-_10450328 | 12.38 |
ENST00000160262.5
|
ICAM3
|
intercellular adhesion molecule 3 |
chr22_+_22676808 | 12.35 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
chr2_+_105471969 | 12.30 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
chr19_-_10445399 | 12.28 |
ENST00000592945.1
|
ICAM3
|
intercellular adhesion molecule 3 |
chr3_-_52860850 | 12.26 |
ENST00000441637.2
|
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
chr22_+_20104947 | 12.23 |
ENST00000402752.1
|
RANBP1
|
RAN binding protein 1 |
chr16_+_33605231 | 12.15 |
ENST00000570121.2
|
IGHV3OR16-12
|
immunoglobulin heavy variable 3/OR16-12 (non-functional) |
chr19_+_58694396 | 12.14 |
ENST00000326804.4
ENST00000345813.3 ENST00000424679.2 |
ZNF274
|
zinc finger protein 274 |
chr14_+_61654271 | 11.97 |
ENST00000555185.1
ENST00000557294.1 ENST00000556778.1 |
PRKCH
|
protein kinase C, eta |
chr8_-_6875778 | 11.96 |
ENST00000535841.1
ENST00000327857.2 |
DEFA1B
DEFA3
|
defensin, alpha 1B defensin, alpha 3, neutrophil-specific |
chr5_-_131347501 | 11.93 |
ENST00000543479.1
|
ACSL6
|
acyl-CoA synthetase long-chain family member 6 |
chr6_+_31554826 | 11.89 |
ENST00000376089.2
ENST00000396112.2 |
LST1
|
leukocyte specific transcript 1 |
chr14_-_21492251 | 11.89 |
ENST00000554398.1
|
NDRG2
|
NDRG family member 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.0 | 240.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
15.5 | 46.4 | GO:1902994 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
14.3 | 57.0 | GO:0002086 | diaphragm contraction(GO:0002086) |
12.0 | 36.1 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
10.7 | 739.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
10.5 | 10.5 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
10.0 | 40.0 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
9.7 | 29.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
9.2 | 27.7 | GO:1903413 | cellular response to bile acid(GO:1903413) |
8.4 | 25.1 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
8.1 | 24.4 | GO:0033212 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
8.1 | 8.1 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
7.9 | 7.9 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
7.8 | 39.2 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
7.7 | 38.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
7.7 | 23.1 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
7.5 | 74.9 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
7.3 | 29.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
7.2 | 21.5 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
7.1 | 92.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
7.0 | 21.1 | GO:0051673 | pore formation in membrane of other organism(GO:0035915) membrane disruption in other organism(GO:0051673) |
7.0 | 34.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
6.8 | 88.6 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
6.5 | 32.7 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
6.5 | 25.9 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
6.3 | 25.4 | GO:1905174 | metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
6.3 | 18.8 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
6.2 | 18.7 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
6.1 | 18.3 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
6.1 | 12.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
5.8 | 17.5 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
5.8 | 46.2 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
5.7 | 28.7 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
5.7 | 5.7 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
5.7 | 28.6 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
5.7 | 17.0 | GO:0061760 | antifungal innate immune response(GO:0061760) |
5.6 | 27.9 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
5.2 | 26.0 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
5.2 | 5.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
5.1 | 30.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
5.1 | 15.2 | GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
5.0 | 20.0 | GO:0042335 | cuticle development(GO:0042335) |
5.0 | 14.9 | GO:0002818 | intracellular defense response(GO:0002818) |
4.9 | 24.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
4.9 | 29.4 | GO:0090131 | mesenchyme migration(GO:0090131) |
4.8 | 19.3 | GO:0090346 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
4.8 | 33.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
4.7 | 18.9 | GO:0035995 | detection of muscle stretch(GO:0035995) |
4.7 | 23.6 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
4.7 | 14.1 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
4.7 | 14.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
4.7 | 14.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
4.7 | 18.6 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
4.6 | 18.6 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
4.6 | 13.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
4.6 | 68.4 | GO:0015671 | oxygen transport(GO:0015671) |
4.6 | 36.5 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
4.5 | 4.5 | GO:0006789 | bilirubin conjugation(GO:0006789) |
4.5 | 13.6 | GO:1904298 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
4.5 | 13.5 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
4.4 | 390.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
4.4 | 13.3 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
4.4 | 4.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
4.4 | 17.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
4.3 | 99.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
4.3 | 13.0 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
4.2 | 12.6 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
4.2 | 4.2 | GO:0042560 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
4.1 | 12.4 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
4.1 | 20.7 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
4.1 | 4.1 | GO:0042701 | progesterone secretion(GO:0042701) |
4.0 | 4.0 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
4.0 | 11.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
4.0 | 27.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
3.9 | 15.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
3.9 | 15.8 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
3.9 | 19.4 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
3.8 | 11.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
3.8 | 26.6 | GO:0006562 | proline catabolic process(GO:0006562) |
3.8 | 11.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
3.8 | 22.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
3.8 | 11.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
3.8 | 22.5 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
3.7 | 18.7 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
3.7 | 22.3 | GO:0070560 | protein secretion by platelet(GO:0070560) |
3.7 | 11.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
3.7 | 7.4 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
3.7 | 69.7 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
3.7 | 14.7 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
3.7 | 18.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
3.6 | 10.9 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
3.6 | 25.4 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
3.6 | 21.6 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
3.6 | 14.4 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
3.6 | 10.8 | GO:0097254 | renal tubular secretion(GO:0097254) |
3.6 | 17.8 | GO:0001878 | response to yeast(GO:0001878) |
3.5 | 3.5 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
3.5 | 10.5 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
3.5 | 14.0 | GO:0060992 | response to fungicide(GO:0060992) |
3.5 | 7.0 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
3.5 | 24.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
3.4 | 3.4 | GO:0001927 | exocyst assembly(GO:0001927) |
3.4 | 10.2 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
3.4 | 10.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
3.4 | 54.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
3.4 | 23.6 | GO:0046618 | drug export(GO:0046618) |
3.3 | 3.3 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
3.3 | 26.6 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
3.3 | 9.9 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
3.3 | 16.4 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
3.3 | 3.3 | GO:0016071 | mRNA metabolic process(GO:0016071) |
3.3 | 13.0 | GO:0005985 | sucrose metabolic process(GO:0005985) |
3.3 | 16.3 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
3.2 | 16.2 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
3.2 | 19.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
3.2 | 3.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
3.2 | 9.7 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
3.2 | 16.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
3.2 | 12.9 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
3.2 | 16.0 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
3.2 | 57.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
3.1 | 22.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
3.1 | 9.4 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
3.1 | 31.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
3.1 | 24.8 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
3.1 | 9.3 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
3.1 | 21.7 | GO:0002933 | lipid hydroxylation(GO:0002933) |
3.1 | 9.3 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
3.1 | 9.2 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
3.0 | 3.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
3.0 | 12.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
3.0 | 9.1 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
3.0 | 15.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
3.0 | 30.0 | GO:0006069 | ethanol oxidation(GO:0006069) |
3.0 | 8.9 | GO:0003095 | pressure natriuresis(GO:0003095) |
3.0 | 3.0 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
3.0 | 11.8 | GO:2000314 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
3.0 | 3.0 | GO:0035106 | operant conditioning(GO:0035106) |
2.9 | 8.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
2.9 | 14.6 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
2.9 | 2.9 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
2.9 | 14.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
2.9 | 17.3 | GO:0006196 | AMP catabolic process(GO:0006196) |
2.9 | 2.9 | GO:0045073 | regulation of chemokine biosynthetic process(GO:0045073) |
2.9 | 5.7 | GO:0001812 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
2.8 | 8.5 | GO:0015729 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
2.8 | 42.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
2.8 | 31.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
2.8 | 11.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
2.8 | 8.5 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
2.8 | 16.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
2.8 | 11.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
2.8 | 11.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
2.8 | 8.3 | GO:0046730 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
2.8 | 8.3 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
2.8 | 5.5 | GO:0072348 | sulfur compound transport(GO:0072348) |
2.8 | 8.3 | GO:2000397 | ubiquitin-dependent endocytosis(GO:0070086) regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
2.7 | 16.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
2.7 | 13.7 | GO:0048539 | bone marrow development(GO:0048539) |
2.7 | 8.2 | GO:0003285 | septum secundum development(GO:0003285) |
2.7 | 2.7 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
2.7 | 8.2 | GO:1904640 | response to methionine(GO:1904640) |
2.7 | 16.1 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
2.7 | 5.3 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
2.7 | 2.7 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
2.6 | 5.3 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
2.6 | 5.2 | GO:0070295 | renal water absorption(GO:0070295) |
2.6 | 7.8 | GO:2000547 | dendritic cell dendrite assembly(GO:0097026) regulation of dendritic cell dendrite assembly(GO:2000547) |
2.6 | 18.2 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
2.6 | 13.0 | GO:0016045 | detection of bacterium(GO:0016045) |
2.6 | 5.2 | GO:0042246 | tissue regeneration(GO:0042246) |
2.6 | 2.6 | GO:0021539 | subthalamus development(GO:0021539) |
2.6 | 5.2 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
2.6 | 7.7 | GO:1902996 | regulation of neurofibrillary tangle assembly(GO:1902996) |
2.6 | 15.4 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
2.6 | 7.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
2.5 | 10.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
2.5 | 15.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
2.5 | 20.2 | GO:0015705 | iodide transport(GO:0015705) |
2.5 | 15.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
2.5 | 2.5 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
2.5 | 17.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
2.5 | 7.4 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
2.5 | 2.5 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
2.5 | 4.9 | GO:0070541 | response to platinum ion(GO:0070541) |
2.5 | 9.9 | GO:0002347 | response to tumor cell(GO:0002347) |
2.4 | 7.3 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
2.4 | 17.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
2.4 | 7.3 | GO:2001303 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
2.4 | 24.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
2.4 | 4.9 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
2.4 | 7.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
2.4 | 9.6 | GO:0071231 | cellular response to folic acid(GO:0071231) |
2.4 | 2.4 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
2.4 | 2.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
2.4 | 47.8 | GO:0045730 | respiratory burst(GO:0045730) |
2.4 | 261.3 | GO:0031295 | T cell costimulation(GO:0031295) |
2.4 | 7.1 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
2.4 | 16.5 | GO:0044351 | macropinocytosis(GO:0044351) |
2.4 | 7.1 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
2.4 | 2.4 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
2.3 | 28.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
2.3 | 34.9 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
2.3 | 7.0 | GO:0003166 | bundle of His development(GO:0003166) cardiac left ventricle formation(GO:0003218) |
2.3 | 6.9 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
2.3 | 9.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
2.3 | 2.3 | GO:0021558 | trochlear nerve development(GO:0021558) |
2.3 | 9.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
2.3 | 11.4 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
2.3 | 6.8 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
2.3 | 11.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
2.3 | 13.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
2.3 | 4.5 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
2.3 | 4.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
2.3 | 9.0 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
2.2 | 6.7 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
2.2 | 4.5 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
2.2 | 13.3 | GO:0019532 | oxalate transport(GO:0019532) |
2.2 | 2.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
2.2 | 11.0 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
2.2 | 13.2 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
2.2 | 6.6 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
2.2 | 15.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.2 | 6.5 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
2.2 | 4.4 | GO:1902218 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
2.2 | 13.0 | GO:0010193 | response to ozone(GO:0010193) |
2.2 | 28.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
2.2 | 10.8 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
2.2 | 19.4 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
2.2 | 25.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
2.1 | 8.6 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
2.1 | 21.4 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
2.1 | 10.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
2.1 | 4.3 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
2.1 | 2.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
2.1 | 6.4 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
2.1 | 10.7 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
2.1 | 33.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
2.1 | 14.6 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
2.1 | 8.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
2.1 | 14.6 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
2.1 | 35.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
2.1 | 8.3 | GO:0070426 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
2.1 | 8.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
2.1 | 12.3 | GO:0071105 | response to interleukin-11(GO:0071105) |
2.0 | 8.2 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
2.0 | 6.1 | GO:0009447 | putrescine catabolic process(GO:0009447) |
2.0 | 2.0 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
2.0 | 2.0 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
2.0 | 14.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
2.0 | 14.2 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
2.0 | 8.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
2.0 | 24.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
2.0 | 12.0 | GO:0050666 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
2.0 | 8.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
2.0 | 6.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
2.0 | 6.0 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
2.0 | 29.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
2.0 | 4.0 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
2.0 | 2.0 | GO:0072672 | neutrophil extravasation(GO:0072672) regulation of neutrophil extravasation(GO:2000389) |
2.0 | 2.0 | GO:0043335 | protein unfolding(GO:0043335) |
2.0 | 3.9 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
2.0 | 17.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
2.0 | 21.5 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
1.9 | 1.9 | GO:0046689 | response to mercury ion(GO:0046689) |
1.9 | 3.9 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
1.9 | 5.8 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
1.9 | 5.8 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
1.9 | 13.4 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
1.9 | 11.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.9 | 19.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
1.9 | 1.9 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
1.9 | 5.7 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.9 | 13.3 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
1.9 | 5.7 | GO:0060061 | Spemann organizer formation(GO:0060061) |
1.9 | 1.9 | GO:0051451 | myoblast migration(GO:0051451) |
1.9 | 5.7 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
1.9 | 7.5 | GO:0032763 | mast cell cytokine production(GO:0032762) regulation of mast cell cytokine production(GO:0032763) |
1.9 | 7.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.9 | 1.9 | GO:0048839 | inner ear development(GO:0048839) |
1.9 | 65.1 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
1.9 | 103.8 | GO:0006953 | acute-phase response(GO:0006953) |
1.8 | 1.8 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
1.8 | 3.7 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
1.8 | 7.4 | GO:1905071 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
1.8 | 3.7 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
1.8 | 240.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
1.8 | 7.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.8 | 10.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.8 | 1.8 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
1.8 | 7.3 | GO:0046967 | cytosol to ER transport(GO:0046967) |
1.8 | 7.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
1.8 | 1.8 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
1.8 | 5.4 | GO:0048867 | stem cell fate determination(GO:0048867) |
1.8 | 5.4 | GO:0060023 | soft palate development(GO:0060023) |
1.8 | 3.6 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
1.8 | 5.3 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
1.8 | 7.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.8 | 7.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.8 | 3.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.8 | 5.3 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
1.8 | 3.5 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) endodermal digestive tract morphogenesis(GO:0061031) |
1.8 | 7.0 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
1.8 | 8.8 | GO:0015811 | L-cystine transport(GO:0015811) |
1.7 | 3.5 | GO:0032660 | regulation of interleukin-17 production(GO:0032660) |
1.7 | 3.5 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
1.7 | 26.2 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.7 | 5.2 | GO:0002027 | regulation of heart rate(GO:0002027) |
1.7 | 3.5 | GO:0008050 | female courtship behavior(GO:0008050) |
1.7 | 1.7 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
1.7 | 17.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.7 | 6.7 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.7 | 5.0 | GO:0035900 | response to isolation stress(GO:0035900) |
1.7 | 10.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.7 | 5.0 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
1.7 | 13.4 | GO:0048102 | autophagic cell death(GO:0048102) |
1.7 | 5.0 | GO:2000538 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
1.7 | 13.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
1.7 | 3.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.7 | 6.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.7 | 26.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.6 | 24.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.6 | 8.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.6 | 3.3 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
1.6 | 13.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.6 | 8.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.6 | 6.5 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
1.6 | 4.9 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
1.6 | 19.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.6 | 6.5 | GO:0044026 | DNA hypermethylation(GO:0044026) |
1.6 | 1.6 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
1.6 | 24.2 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
1.6 | 9.7 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
1.6 | 6.4 | GO:0043129 | surfactant homeostasis(GO:0043129) |
1.6 | 1.6 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.6 | 6.4 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
1.6 | 1.6 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
1.6 | 84.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
1.6 | 1.6 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
1.6 | 6.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.6 | 17.3 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.6 | 6.3 | GO:0008228 | opsonization(GO:0008228) |
1.6 | 3.1 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
1.6 | 1.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.6 | 4.7 | GO:0071025 | RNA surveillance(GO:0071025) |
1.5 | 17.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
1.5 | 7.7 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
1.5 | 3.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.5 | 10.8 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.5 | 16.9 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.5 | 4.6 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
1.5 | 1.5 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
1.5 | 6.0 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
1.5 | 9.0 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
1.5 | 10.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
1.5 | 6.0 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
1.5 | 1.5 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
1.5 | 3.0 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
1.5 | 1.5 | GO:0032620 | interleukin-17 production(GO:0032620) |
1.5 | 7.4 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.5 | 4.4 | GO:0046968 | peptide antigen transport(GO:0046968) |
1.5 | 10.3 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
1.5 | 10.2 | GO:0006116 | NADH oxidation(GO:0006116) |
1.5 | 4.4 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
1.5 | 4.4 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
1.5 | 7.3 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
1.5 | 17.4 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
1.4 | 4.3 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
1.4 | 2.9 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
1.4 | 4.3 | GO:0035565 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
1.4 | 8.7 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
1.4 | 17.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
1.4 | 4.3 | GO:0032571 | response to vitamin K(GO:0032571) |
1.4 | 1.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
1.4 | 83.3 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
1.4 | 2.9 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
1.4 | 4.3 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
1.4 | 1.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.4 | 4.3 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
1.4 | 2.8 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.4 | 4.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
1.4 | 4.2 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
1.4 | 2.8 | GO:0070781 | response to biotin(GO:0070781) |
1.4 | 9.8 | GO:0030432 | peristalsis(GO:0030432) |
1.4 | 2.8 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
1.4 | 23.6 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
1.4 | 4.2 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
1.4 | 4.2 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
1.4 | 4.1 | GO:0070431 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
1.4 | 4.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.4 | 5.5 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
1.4 | 1.4 | GO:1990637 | response to prolactin(GO:1990637) |
1.4 | 4.1 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
1.4 | 12.3 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
1.4 | 1.4 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.4 | 1.4 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
1.4 | 1.4 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
1.4 | 35.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.4 | 1.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
1.3 | 1.3 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
1.3 | 2.7 | GO:0038155 | positive regulation of T-helper 1 type immune response(GO:0002827) interleukin-23-mediated signaling pathway(GO:0038155) regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
1.3 | 4.0 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
1.3 | 24.0 | GO:0097186 | amelogenesis(GO:0097186) |
1.3 | 1.3 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
1.3 | 1.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.3 | 18.6 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
1.3 | 10.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.3 | 27.8 | GO:0033198 | response to ATP(GO:0033198) |
1.3 | 2.6 | GO:0070944 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
1.3 | 5.3 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
1.3 | 2.6 |